AuraSense Therapeutics Receives Series B Round

  • Feed Type
  • Date
    7/31/2013
  • Company Name
    AuraSense Therapeutics
  • Mailing Address
    8045 Lamon Avenue Skokie, IL 60077
  • Company Description
    AuraSense Therapeutics is a development-stage biotechnology company founded to pursue the unique commercial potential of Spherical Nucleic Acid (SNA) constructs. These novel constructs possess unparalleled biocompatibility and versatility as therapeutics.
  • Website
    http://www.aurasensetherapeutics.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Series B
  • Proceeds Purposes
    We look forward to taking our first SNA constructs through the preclinical development phase.
  • M&A Terms
  • Venture Investor
    AbbVie
  • Venture Investor
    Investor
  • Venture Investor
    Investor
  • Venture Investor
    Investor
  • Venture Investor
    Investor

By posting a comment, you agree to our terms and conditions.